Clinical trial
The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public…
NCT00407199 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00407199 |
|---|---|
| Title | The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment |
| Official title | The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Effects on Cue Reactivity in Response to Virtual Reality Public Speaking Environment |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | quetiapine |
| Enrollment | 20 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: